Strategic Finance Lead - PDS & R&D Performance

Lundbeck; Kraków; On-site; PLN 246,000 - 338,360; Full time

Benefits offered by this job

Flexible working arrangements

Cafeteria program

Unique recognition system

Holiday bonus

Private healthcare

Employee capital plans

Job summary

Lundbeck Krakow is seeking a Senior Finance Planning & Performance Leading Controller to partner with Executive Management across PDS and R&D, driving financial planning, performance management, and strategic decision support while mentoring junior finance colleagues.

You will influence key business decisions through analysis, business case modelling, and long-term planning, contributing to global initiatives and sustainable growth for brain-disease therapies.

Qualifications

• Minimum 10 years of progressive experience in controlling, finance, or accounting in an international environment.
• Experience partnering with senior executives to influence business decisions.
• Strong communication and presentation skills with extensive stakeholder management.
• Ability to translate data and risk into actionable recommendations.

Responsibilities

• Lead financial planning, performance management and strategic decision support for PDS and R&D.
• Partner with senior executives and mentor junior finance staff.
• Contribute to global initiatives and process improvements within Group Finance.

Skills

Leadership capabilities

Senior stakeholder management

Strategic decision support

Data translation to insights

Coaching and mentoring

Excellent communication

Education

University degree in Finance/Accounting

Professional accounting qualifications (ACCA/ACA/CPA/CIMA/CIA)

Job description

Lundbeck Krakow is seeking a Senior Finance Planning & Performance Leading Controller to partner with Executive Management across PDS and R&D, driving financial planning, performance management, and strategic decision support while mentoring junior finance colleagues.

You will influence key business decisions through analysis, business case modelling, and long-term planning, contributing to global initiatives and sustainable growth for brain-disease therapies.